Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04815772
Other study ID # 56665618-204.01.07-22
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date March 1, 2021

Study information

Verified date March 2021
Source Okan University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of present study was to evaluate how the 2018 classification reflects the severity, extent and progression of the disease, taking into account the risk factors for periodontal disease, smoking and diabetes, when compared with the 1999 classification.


Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date March 1, 2021
Est. primary completion date January 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with a complete periodontal chart and full mouth radiographic series at baseline - Diabetes Mellitus:Patients who consulted by an internist/endocrinologist and underwent HbA1c measurements in the last three months. - Smoking status:All current smokers who had smoked more than 100 cigarettes in their lifetimes and used cigarettes for more than five years - Patients meeting the case definition of periodontitis - Relative radiographic bone loss(in %) was assessed on peri-apical radiograph films Exclusion Criteria: - individuals with a systemic disease other than diabetes - Smokers not reporting the number of cigarette/days or patient(s) with diabetes that do not report Hemoglobin A1c (HbA1c) test results for diabetes. - individuals who do not suffer from periodontitis - Patients with inaccessible files because of bad debt, destroyed record, or deceased.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Istanbul Okan University Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Okan University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The advantages of including the effect of diabetes and smoking on periodontal disease in the 2018 classification compared to the 1999 classification In our study, both classifications reflected the severity of periodontal disease differently. The 2018 classification outperformed the 1999 classification for staging and grading of periodontitis severity and progression. Consideration of the risk factors listed in the 2018 classification has been useful approach for correct diagnosis, evidence-based clinical decisions, prognosis of treatment, and periodontal disease prevention. The 2018 periodontal disease classification is more detailed and comprehensive than the 1999 classification, and this classification is thought to revise the criticisms of the 1999 classification. The present retrospective study included individuals who were examined and had periodontal measurements made and recorded at the Istanbul Okan University Periodontology Department between 09/01/2018 and 12/01/2019.
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A